NovoCure
NVCR
NVCR
316 hedge funds and large institutions have $9.01B invested in NovoCure in 2021 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 106 increasing their positions, 115 reducing their positions, and 81 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
48% less capital invested
Capital invested by funds: $17.2B → $9.01B (-$8.21B)
49% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 81
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Holders
316
Holding in Top 10
2
Calls
$252M
Puts
$192M
Top Buyers
| 1 | +$164M | |
| 2 | +$90M | |
| 3 | +$27.5M | |
| 4 |
BlackRock
New York
|
+$23.7M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$18.2M |
Top Sellers
| 1 | -$156M | |
| 2 | -$58.6M | |
| 3 | -$49.9M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$28.1M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$25.3M |